Free Trial

Voyager Therapeutics (VYGR) SEC Filings & 10K Form

Voyager Therapeutics logo
$5.36 +0.09 (+1.71%)
(As of 11/20/2024 ET)

Recent Voyager Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
5:13 PM
EcoR1 Capital, LLC (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
09/05/2024
7:06 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
3:10 PM
Jorgensen Nathan D. (Reporting)
Voyager Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2024
3:11 PM
Jorgensen Nathan D. (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
6:06 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:15 PM
GERAGHTY JAMES A (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:16 PM
Higgins Michael J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:17 PM
Hyman Steven (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:19 PM
MACKEY CATHERINE J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:20 PM
Onyia Jude (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:20 PM
PIERCE GLENN (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:05 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:01 PM
Voyager Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
3:00 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
4:20 PM
Voyager Therapeutics (Filer)
Form DEF 14A
04/25/2024
4:20 PM
Voyager Therapeutics (Filer)
Form DEFA14A
04/25/2024
4:22 PM
Voyager Therapeutics (Filer)
Form ARS
04/02/2024
2:24 PM
Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
2:29 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
4:24 PM
Ferguson Toby (Reporting)
Voyager Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/26/2024
4:27 PM
Ferguson Toby (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
6:03 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
3:00 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
3:30 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:32 PM
PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:34 PM
Sandrock Alfred (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
2:13 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
2:16 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
2:18 PM
PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
2:20 PM
Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:11 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
1:35 PM
ARMISTICE CAPITAL, LLC (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G
01/19/2024
3:32 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:34 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:20 PM
Voyager Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/17/2024
2:21 PM
Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2024
2:33 PM
Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:49 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:20 PM
Voyager Therapeutics (Filer)
Form 424B5
01/02/2024
6:05 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
12/06/2023
6:04 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VYGR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners